Quick Summary:
In the rapidly evolving world of biomedicine, the global glycomics market plays a pivotal role in pioneering advancements in health and disease management. Glycomics, the comprehensive study of glycomes, drives the understanding of cellular function and interaction. This study's insights are instrumental in various fields, particularly in diagnostics, drug discovery, and immunology.
The escalating prevalence of chronic diseases is fuelling the demand for highly efficient, research-based solutions, thus positively affecting the market growth of glycomics. Simultaneously, continuous investments into research and development activities by leading market players are shaping the future of therapeutics, with special emphasis on the advancement of technologies such as high-performance liquid chromatography (HPLC), mass spectrometry (MS), and capillary electrophoresis (CE). Additional factors such as the dynamic growth of the pharmaceutical industry, increasing clinical trials, and advancements in healthcare infrastructure globally serve as catalysts for the market's further expansion.
This comprehensive market research report presents an in-depth analysis, highlighting current trends and forecasts for global glycomics. It details the various segments of the market, industry landscape, and the key players at the forefront of driving innovation. This information is vital to any interested party, providing the much-needed foundation for informed decision-making in this distinctive and highly promising field.
Glycomics refers to a study that aids in defining or quantifying the glycome of a cell, tissue, or organism. It mainly assists in identifying the structure and function of the complete set of glycans produced in a single organism and determining all the genes that encode glycoproteins. It also aids in establishing the role of carbohydrate-protein interactions in cell-cell communication. As a result, glycomics finds extensive application in diagnostics, drug discovery, and immunology across the globe.
Glycomics Market Trends:
Presently, there is a rise in the prevalence of chronic diseases on account of sedentary lifestyles and the growing number of individuals who smoke and consume alcohol. In line with this, the coronavirus disease (COVID-19) outbreak has positively influenced the demand for vaccine and treatment drugs to prevent the spread of the pandemic worldwide. This, in turn, is strengthening the growth of the glycomics market. Besides this, glycomics is gaining preference for training and educational purposes around the world. This, in confluence with its extensive applicability in research centers due to the increasing adoption of glycan structure data analysis, is contributing to market growth. Furthermore, leading market players are continuously funding research and development (R&D) activities to enhance the ability of structurally complex glycans to be employed as therapeutics. Consequently, they are developing advanced technologies, such as high-performance liquid chromatography (HPLC), mass spectrometry (MS), and capillary electrophoresis (CE) in chemical and biochemical research. Moreover, a growing number of Contract Research Organizations (CROs) for the development and production of drugs and biologics is driving the market. Some of the other factors, such as the thriving pharmaceutical industry, rising number of clinical trials, and the improving healthcare infrastructure, are anticipated to propel the market growth.Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global glycomics market report, along with forecasts at the global, regional and country level from 2023-2028. The report has categorized the market based on product, application and end user.Breakup by Product:
- Enzymes
- Glycosidases
- Glycosyltransferases
- Neuraminidases
- Sialyltransferases
- Others
- Instruments
- Mass Spectrometers
- HPLC
- MALDI-TOF
- Array systems
- Others
- Kits
- Glycan Labeling Kits
- Glycan Purification Kits
- Glycan Release Kits
- Others
- Reagents
- Glycoproteins
- Monosaccharides
- Oligosaccharides
- Others
Breakup by Application:
- Drug Discovery and Development
- Diagnostics
- Others
Breakup by End User:
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Asparia Glycomics, Bruker Corporation, Danaher Corporation, Dextra Laboratories Limited (New Zealand Pharmaceuticals Limited), Merck KGaA, New England Biolabs, RayBiotech Life Inc., Shimadzu Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc. and Waters Corporation.Key Questions Answered in This Report
1. What was the size of the global glycomics market in 2022?2. What is the expected growth rate of the global glycomics market during 2023-2028?
3. What are the key factors driving the global glycomics market?
4. What has been the impact of COVID-19 on the global glycomics market?
5. What is the breakup of the global glycomics market based on the product?
6. What is the breakup of the global glycomics market based on the application?
7. What is the breakup of the global glycomics market based on end user?
8. What are the key regions in the global glycomics market?
9. Who are the key players/companies in the global glycomics market?
What is the estimated value of the Global Glycomics Market?
What is the growth rate of the Global Glycomics Market?
What is the forecasted size of the Global Glycomics Market?
Who are the key companies in the Global Glycomics Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 146 |
| Published | September 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 1.4 Billion |
| Forecasted Market Value ( USD | $ 2.8 Billion |
| Compound Annual Growth Rate | 12.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
Table of Contents
Companies Mentioned
- Agilent Technologies Inc.
- Asparia Glycomics
- Bruker Corporation
- Danaher Corporation
- Dextra Laboratories Limited (New Zealand Pharmaceuticals Limited)
- Merck KGaA
- New England Biolabs
- RayBiotech Life Inc.
- Shimadzu Corporation
- Taka
Methodology
LOADING...
